BLOG / 🇺🇸 United States · · daily

All HHS Contracts — November 11, 2026

All HHS Contracts

By Gunpowder Editorial ·

7 total filings analysed

Executive Summary

This digest covers 7 HHS contracts totaling $224.1M, all civilian (0% defense), with an average signal strength of 3.4/10. The portfolio is dominated by nonprofit and public-entity recipients (NYC Health + Hospitals, MDRC, RTI, Thomas Jefferson University) and private firms (Myers and Stauffer, Red Eagle JV, Kelly Services), leaving only Kelly Services as a directly investable public equity.

The highest-conviction signal is the $58.7M CDC award to NYC Health + Hospitals for a 9/11 Survivor Clinical Center, which carries a $165.9M ceiling and runs through 2030, underscoring sustained public-health funding. A key risk is that most contracts are cost-reimbursement or firm-fixed-price with limited margin upside, and several are already 50-70% outlayed, reducing incremental revenue visibility. Investors should watch option exercises (e.g., RTI's $29.5M option tail) and recompete dates (Myers and Stauffer's February 2028 potential end) for sector read-throughs, but direct equity catalysts are minimal.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior All HHS Contracts digest from October 30, 2026.

Investment Signals (4)

  • CDC awards $58.7M to NYC Health + Hospitals for 9/11 Survivor Clinical Center, with $165.9M ceiling (MEDIUM)
    ▲

    The New York City Health and Hospitals Corporation received a $58.7M obligated cost-no-fee contract from CDC to operate a 9/11 Survivor Clinical Center of Excellence, with a base-plus-options ceiling of $165.9M through 2030. This signals sustained federal commitment to 9/11 survivor health programs, though the recipient is a public hospital corporation with no direct equity exposure.

  • RTI wins $24.8M MEPS contract with $54.3M ceiling, $29.5M in unexercised options (MEDIUM)
    ▲

    Research Triangle Institute received a $24.8M cost-plus-award-fee contract for the Medical Expenditure Panel Survey, with a base-plus-options ceiling of $54.3M, leaving $29.5M in potential option value. This indicates HHS's continued investment in health-data infrastructure, but RTI is a nonprofit with no public equity.

  • Myers and Stauffer $54.2M CMS contract is 56% outlayed, options through Feb 2028 (MEDIUM)
    ▲

    Myers and Stauffer's $54.2M time-and-materials delivery order for CMS quality assurance has $30.4M already outlayed, leaving only $13.3M in unexercised options. The contract's potential end date is February 2028, after which recompete risk emerges for this private LLC.

  • Kelly Services $12.6M NIH/NIDA task order is 69% outlayed, potential extension beyond March 2027 (LOW)
    ▲

    Kelly Services received a $12.6M firm-fixed-price delivery order from NIH's National Institute on Drug Abuse, with $8.7M already outlayed (69%). As the only public company in this digest, Kelly's modest award provides a small but tangible read-through to its government staffing segment.

Risk Flags (3)

  • Budget [MEDIUM RISK]
    ▼

    All 7 contracts are civilian HHS awards, with no defense exposure. Budget pressures on non-defense discretionary spending, including potential continuing resolutions, could delay option exercises or new awards.

  • Competition [MEDIUM RISK]
    ▼

    Myers and Stauffer's $54.2M CMS contract has only $13.3M in unexercised options and a potential end date of February 2028, creating recompete risk. Similarly, Kelly Services' task order ends March 2027 with no disclosed options.

  • Concentration [LOW RISK]
    ▼

    The portfolio is heavily weighted toward nonprofit and public-entity recipients (NYC Health + Hospitals, MDRC, RTI, Thomas Jefferson University), which together account for $140.1M (62.5%) of total obligations. These entities are not investable via public equity, limiting direct market impact.

Opportunities (3)

  • ◆

    RTI's $24.8M MEPS contract has $29.5M in unexercised options, representing significant potential upside if all options are exercised through 2030. This reflects HHS's ongoing need for survey and data-collection services.

  • ◆

    Red Eagle JV, a small business with multiple disadvantaged designations, won a $17.2M firm-fixed-price contract for the Mescalero Indian Hospital renovation. This highlights opportunities in IHS construction set-asides for small and disadvantaged businesses.

  • ◆

    Kelly Services' $12.6M NIDA task order, while modest, could lead to follow-on awards under the same SOAR vehicle, given the 69% outlay rate and performance through March 2027.

Sector Themes (3)

  • ◆

    HHS agencies (CDC, NIH, CMS) continue to fund long-duration public health programs, as evidenced by the $58.7M 9/11 survivor center and $25.99M filovirus vaccine R&D contract. These awards extend through 2028-2030, indicating multi-year budget commitments.

  • ◆

    RTI's $24.8M MEPS contract and Myers and Stauffer's $54.2M CMS quality assurance work highlight ongoing federal investment in healthcare data collection and analysis, with NAICS codes pointing to computing infrastructure and professional services.

  • ◆

    Red Eagle JV's $17.2M set-aside contract for hospital renovation demonstrates IHS's use of small business preferences, including Native American and service-disabled veteran designations.

Watch List (4)

  • 👁

    {"entity" => "Research Triangle Institute", "reason" => "RTI's $24.8M MEPS contract has $29.5M in unexercised options, with potential end date of June 2030. Option exercises would signal continued HHS data spending.", "trigger" => "Option exercise announcements or modifications"}

  • 👁

    {"entity" => "Myers and Stauffer LC", "reason" => "The $54.2M CMS contract has only $13.3M in remaining options and ends February 2028. Recompete could open the door for public companies.", "trigger" => "Recompete solicitation for CMS QITS/IRIS"}

  • 👁

    {"entity" => "Kelly Services, Inc.", "reason" => "The $12.6M NIDA task order is 69% outlayed and ends March 2027. Extension or follow-on would provide incremental revenue.", "trigger" => "Task order extension or new award under SOAR vehicle"}

  • 👁

    {"entity" => "New York City Health and Hospitals Corporation", "reason" => "The $58.7M CDC contract has $107.2M in unexercised options through 2030. Option exercises would indicate sustained 9/11 survivor program funding.", "trigger" => "CDC option exercise decisions"}

Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 7 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: All HHS Contracts

🇺🇸 More from United States

View all →